Filing Flows › Sanofi (SNY) › Q2 2026 › vs Q2 2025
Sanofi (SNY) Q2 2026 vs Q2 2025 (year over year)
Sanofi's revenue rose $1.6B (+16%) from $10.0B in Q2 2025 to $11.6B in Q2 2026.
Sanofi, Q2 2026: revenue $11.6B (+16% year over year), operating margin 9.0%, net earnings $377M. The chart draws each line against Q2 2025, the increases inside each band.
Every line
| Line | Q2 2026 | Q2 2025 | Change | % |
|---|---|---|---|---|
| Revenue | $11.6B | $10.0B | $1.6B | +16% |
| Income tax benefit | $451M | $230M | $221M | +96% |
| Costs & expenses | $12.0B | $12.5B | −$416M | -3% |
| Operating costs | $10.6B | $8.5B | $2.0B | +24% |
| Interest & other, net | $1.1B | −$2.2B | $3.4B | — |
| Net earnings | $377M | $3.9B | −$3.6B | -90% |
| Cost of revenue | $2.3B | $2.3B | $62.0M | +3% |
| Research & development | $2.2B | $1.9B | $324M | +17% |
| Other operating costs | $6.0B | $4.4B | $1.6B | +38% |
Questions
How much did Sanofi's revenue grow year over year in Q2 2026?
Sanofi's revenue rose $1.6B (+16%) from $10.0B in Q2 2025 to $11.6B in Q2 2026.